Warriors' Andrew Wiggins enters COVID-19 protocol | Inquirer Sports

Warriors’ Andrew Wiggins enters COVID-19 protocol

/ 10:51 AM December 20, 2021
Andrew Wiggins Warriors

Andrew Wiggins #22 of the Golden State Warriors handles the ball during the first half of the NBA game at Footprint Center on November 30, 2021 in Phoenix, Arizona. Christian Petersen/Getty Images/AFP

Golden State forward Andrew Wiggins was placed in the COVID-19 protocol on Sunday and will miss the Warriors’ Monday home game against the Sacramento Kings.

Wiggins will be one of two starters sitting out the contest due to the NBA’s health and safety protocol. Guard Jordan Poole is slated to miss his third straight game.


Wiggins received the vaccine in early October after being turned down for a religious exemption by the NBA. He said he felt “forced” to get vaccinated.

The 26-year-old was facing the possibility of not being able to play in home games due to the city of San Francisco’s vaccine mandate.


Wiggins is enjoying a strong season with averages of 18.7 points and 4.5 rebounds in 29 games. He sat out the Warriors’ 119-100 road loss to the Toronto Raptors on Saturday due to a knee injury.

Poole, 22, is averaging 17.9 points, 3.4 rebounds and 3.4 assists — all career highs — through 28 starts in his third season with the Warriors.


Raptors return to action, knock off shorthanded Warriors

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Andrew Wiggins, Golden State Warriors, NBA COVID-19 protocol
For feedback, complaints, or inquiries, contact us.

Subscribe to our sports news

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.